<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00991341</url>
  </required_header>
  <id_info>
    <org_study_id>676</org_study_id>
    <secondary_id>U01HL072268</secondary_id>
    <secondary_id>HL072268</secondary_id>
    <secondary_id>HL072033</secondary_id>
    <secondary_id>HL072291</secondary_id>
    <secondary_id>HL072196</secondary_id>
    <secondary_id>HL072289</secondary_id>
    <secondary_id>HL072248</secondary_id>
    <secondary_id>HL072191</secondary_id>
    <secondary_id>HL072299</secondary_id>
    <secondary_id>HL072305</secondary_id>
    <secondary_id>HL072274</secondary_id>
    <secondary_id>HL072028</secondary_id>
    <secondary_id>HL072359</secondary_id>
    <secondary_id>HL072072</secondary_id>
    <secondary_id>HL072355</secondary_id>
    <secondary_id>HL072283</secondary_id>
    <secondary_id>HL072346</secondary_id>
    <secondary_id>HL072331</secondary_id>
    <secondary_id>HL072290</secondary_id>
    <nct_id>NCT00991341</nct_id>
  </id_info>
  <brief_title>Red Cell Storage Duration Study</brief_title>
  <acronym>RECESS</acronym>
  <official_title>Red Cell Storage Duration Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New England Research Institutes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New England Research Institutes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RECESS study will compare the effects of transfusing red blood cell units stored &lt;= 10
      days vs. red blood cell units stored &gt;= 21 days, in patients who are undergoing complex
      cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis
      is that there is a clinically important difference between the effects of shorter-storage red
      cell units and longer-storage red cell units on clinical outcomes and mortality risk.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Change in the Composite Multiple Organ Dysfunction Score (MODS) From the Pre-operative Baseline. The Worst Post-operative Values of Each Component of MODS Will be Used to Calculate the Change in MODS.</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
    <description>The follow-up MODS used to calculate 7-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 7, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored [subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 7-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>28 days post-surgery</time_frame>
    <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed for all-cause mortality until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analysis started at randomization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Multiple Organ Dysfunction Score From Pre-operative Baseline.</measure>
    <time_frame>Through 28 days post-surgery, hospital discharge, or death, whichever occurs first</time_frame>
    <description>The follow-up MODS used to calculate 28-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 28, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored[subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 28-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Major In-hospital Post-operative Complications (Death, Stroke, Myocardial Infarction, Renal Failure, Culture-proven Sepsis/Septic Shock)</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Major Cardiac Events (Death, Myocardial Infarction, Low Cardiac Output, Ventricular Tachycardia, Ventricular Fibrillation)</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Major Pulmonary Events (Any Mechanical Ventilation From 48 Hours Post-operation to Day 7, Hospital Discharge or Death, Whichever Comes First, or Pulmonary Embolism)</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation Duration</measure>
    <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
    <description>Because some subjects may experience multiple periods of ventilator use, the total duration that they were on a ventilator was compared between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Serum Creatinine From Pre-operative Value to Worst Post-operative Value</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Troponin-I From Pre-operative Value to Worst Post-operative Value</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lactate From Pre-operative Value to Worst Post-operative Value</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
    <description>The arterial lactate levels were adjusted to make them comparable to venous lactate levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bilirubin From Pre-operative Value to Worst Post-operative Value</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ALT From Pre-operative Value to Worst Post-operative Value (for Pediatric Subjects Only)</measure>
    <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to First Bowel Movement</measure>
    <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
    <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative bowel movement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to First Solid Food</measure>
    <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
    <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative solid food.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days Alive and Ventilator Free Through Post-op Day 28</measure>
    <time_frame>Through post-op day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Mechanical Ventilation More Than 48 Hours Post-operation</measure>
    <time_frame>48 hours post-operation through day 28, hospital discharge, or death, whichever occurs first</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1481</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Erythrocyte Transfusion</condition>
  <arm_group>
    <arm_group_label>Shorter-storage red blood cell units</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red blood cell units stored &lt;= 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Longer-storage red blood cell units</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red blood cell units stored &gt;= 21 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Red blood cell units stored &lt;= 10 days</intervention_name>
    <description>Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
    <arm_group_label>Shorter-storage red blood cell units</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Red blood cell units stored &gt;= 21 days</intervention_name>
    <description>Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
    <arm_group_label>Longer-storage red blood cell units</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;= 12 years old

          -  &gt;= 40 kg body weight

          -  Scheduled complex cardiac surgery with planned use of median sternotomy.

          -  Patients ≥ 18 years must have a Transfusion Risk Understanding Scoring Tool (TRUST)
             probability score ≥ 3

        Exclusion Criteria:

          -  Refusal of blood products

          -  Planned surgery is minimally invasive

          -  Known transfusion reaction history

          -  Requirement for washed products, volume reduced products, or products with additive
             solution removed

          -  Expected residual cyanosis with O2 saturation &lt; 90

          -  Left ventricular assist device (LVAD) or Extracorporeal membrane oxygenation (ECMO)
             support pre-operatively or planned need post-operatively

          -  Cardiogenic shock requiring pre-operative placement of an Intra-aortic balloon pump
             (IABP) (IABP done for unstable angina or prophylactically for low ejection fraction is
             not excluded)

          -  Planned Deep Hypothermic Circulatory Arrest (DHCA)

          -  Renal dysfunction requiring pre-operative renal replacement therapies such as
             hemodialysis (HD) or continuous venovenous hemofiltration (CVVH)

          -  Planned use of alternative to heparin, e.g. bivalirudin

          -  Planned use of autologous or directed donations

          -  Prior RBC transfusion during hospitalization for the study-qualifying surgery

          -  Prior randomization into the RECESS study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan F Assmann, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New England Research Institutes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Sloan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Ortel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cassandra Josephson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Stowell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meghan Delaney, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington/Fred Hutchinson Cancer Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Steiner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota Medical Center Fairview</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Darrell Triulzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh Presbyterian and Shadyside</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lynne Uhl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Kaufman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Bussel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Ness, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Raife, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rhonda Cooke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nigel Key, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeff Carson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers, The State University of New Jersey</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent Scavo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana/Ohio Heart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wade Fischer, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Froedtert Memorial Lutheran Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pampee Young, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathy Puca, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Luke's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James George, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory Nuttall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur Bracey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Engleman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baystate Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip Greileich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kent Berg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Hunsaker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Elizabeth's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ronald Miles, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aspirus Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ravindra Karanam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barnabas Health, Newark Beth Israel Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cornelius Dyke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanford Heart Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eldad Hod, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Hospital</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana/Ohio Heart</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital/University of Minnesota Medical Center Fairview</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Health Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical School</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Heart Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Presbyterian and Shadyside</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC-Mercy Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37323</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veterans Administration Puget Sound</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert Memorial Lutheran Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Lukes Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aspirus Vascular Heart Center</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <results_first_submitted>February 17, 2015</results_first_submitted>
  <results_first_submitted_qc>May 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 9, 2015</results_first_posted>
  <last_update_submitted>May 22, 2015</last_update_submitted>
  <last_update_submitted_qc>May 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>Red blood cell</keyword>
  <keyword>Transfusion</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>RECESS recruitment took place at 33 US hospitals, beginning in January 2010 and ending in January 2014.</recruitment_details>
      <pre_assignment_details>Randomization was stratified by age (≥18 yrs or &lt;18 yrs) and by whether or not the subject was in the ICU prior to surgery. A subject could not be randomized unless prior to surgery but no earlier than one calendar day prior to surgery, the transfusion service had enough suitable units of both storage durations to satisfy the cross-match request.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Shorter-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
        <group group_id="P2">
          <title>Longer-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="742"/>
                <participants group_id="P2" count="739"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="538"/>
                <participants group_id="P2" count="560"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="204"/>
                <participants group_id="P2" count="179"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>no surgery w/in 30 days of randomization</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>no RBCs received 96hrs after randomized</title>
              <participants_list>
                <participants group_id="P1" count="186"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
      <group_list>
        <group group_id="B1">
          <title>Shorter-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
        <group group_id="B2">
          <title>Longer-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="538"/>
            <count group_id="B2" value="560"/>
            <count group_id="B3" value="1098"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73" lower_limit="66" upper_limit="80"/>
                    <measurement group_id="B2" value="72" lower_limit="65" upper_limit="79"/>
                    <measurement group_id="B3" value="72" lower_limit="66" upper_limit="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="536"/>
                    <measurement group_id="B2" value="558"/>
                    <measurement group_id="B3" value="1094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="310"/>
                    <measurement group_id="B2" value="313"/>
                    <measurement group_id="B3" value="623"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="228"/>
                    <measurement group_id="B2" value="247"/>
                    <measurement group_id="B3" value="475"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="506"/>
                    <measurement group_id="B2" value="513"/>
                    <measurement group_id="B3" value="1019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="485"/>
                    <measurement group_id="B2" value="493"/>
                    <measurement group_id="B3" value="978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="538"/>
                    <measurement group_id="B2" value="560"/>
                    <measurement group_id="B3" value="1098"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75" lower_limit="65" upper_limit="89"/>
                    <measurement group_id="B2" value="74" lower_limit="66" upper_limit="86"/>
                    <measurement group_id="B3" value="75" lower_limit="66" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165" lower_limit="158" upper_limit="173"/>
                    <measurement group_id="B2" value="165" lower_limit="160" upper_limit="175"/>
                    <measurement group_id="B3" value="165" lower_limit="158" upper_limit="173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Minimum TRUST Score</title>
          <description>Per Alghamdi et al article in Transfusion (2006), the Transfusion Risk Understanding Scoring Tool (TRUST) score is an additive algorithm that provides an overall score that ranges from 0 to 8. The interpretation of the total score as it relates to the probability of exposure to transfusion is as follows: 0=baseline risk; 1=low risk; 2=intermediate risk; 3=high risk; 4-8=very high risk.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="222"/>
                    <measurement group_id="B3" value="388"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="210"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="132"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ICU Status at Randomization</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>In ICU Before Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not in ICU Before Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="504"/>
                    <measurement group_id="B2" value="527"/>
                    <measurement group_id="B3" value="1031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Multiple Organ Dysfunction Score</title>
          <description>Per Marshall et al article in Critical Care Medicine (1995), increasing Multiple Organ Dysfunction Scores correlated with in-hospital mortality. No deaths occurred in patients with a MODS score of 0. The approximate in-hospital mortality rates were 6% for patients with MODS score of 1-4 points, 15% for patients with scores between 5-8, 50% for patients with scores between 8-12, 68% for patients with scores 13-16, 80% for patients with scores 17-20 and 100% for scores &gt; 20.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="252"/>
                    <measurement group_id="B2" value="293"/>
                    <measurement group_id="B3" value="545"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                    <measurement group_id="B2" value="194"/>
                    <measurement group_id="B3" value="417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ABO Blood Group</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>O</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="235"/>
                    <measurement group_id="B3" value="444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="240"/>
                    <measurement group_id="B2" value="241"/>
                    <measurement group_id="B3" value="481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemoglobin</title>
          <units>g/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.7" lower_limit="10.7" upper_limit="12.8"/>
                    <measurement group_id="B2" value="12.0" lower_limit="10.8" upper_limit="13.0"/>
                    <measurement group_id="B3" value="11.9" lower_limit="10.7" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Change in the Composite Multiple Organ Dysfunction Score (MODS) From the Pre-operative Baseline. The Worst Post-operative Values of Each Component of MODS Will be Used to Calculate the Change in MODS.</title>
        <description>The follow-up MODS used to calculate 7-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 7, hospital discharge, or death, whichever occurred first, even if a subject’s worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored [subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 7-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>The Change in the Composite Multiple Organ Dysfunction Score (MODS) From the Pre-operative Baseline. The Worst Post-operative Values of Each Component of MODS Will be Used to Calculate the Change in MODS.</title>
          <description>The follow-up MODS used to calculate 7-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 7, hospital discharge, or death, whichever occurred first, even if a subject’s worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored [subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 7-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>MOD score points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="534"/>
                <count group_id="O2" value="553"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.49" spread="3.62"/>
                    <measurement group_id="O2" value="8.66" spread="3.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.44</p_value>
            <method>ANCOVA</method>
            <method_desc>The treatment groups were compared with respect to the change in MODS, adjusting for baseline MODS.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.60</ci_lower_limit>
            <ci_upper_limit>0.26</ci_upper_limit>
            <estimate_desc>The longer storage red blood cell units arm is the reference category. After adjusting for baseline MODS, the difference in the means was -0.17, positive values are in favor of longer storage duration.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality</title>
        <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed for all-cause mortality until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analysis started at randomization.</description>
        <time_frame>28 days post-surgery</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality</title>
          <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed for all-cause mortality until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analysis started at randomization.</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>participants with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="538"/>
                <count group_id="O2" value="560"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.50</p_value>
            <method>Regression, Cox</method>
            <method_desc>The treatment groups were compared with respect to all-cause mortality, adjusting for baseline MODS.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.48</ci_lower_limit>
            <ci_upper_limit>1.43</ci_upper_limit>
            <estimate_desc>The longer storage duration arm is the reference category.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Multiple Organ Dysfunction Score From Pre-operative Baseline.</title>
        <description>The follow-up MODS used to calculate 28-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 28, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored[subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 28-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
        <time_frame>Through 28 days post-surgery, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Multiple Organ Dysfunction Score From Pre-operative Baseline.</title>
          <description>The follow-up MODS used to calculate 28-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 28, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored[subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation], then a post-op MODS score was set to missing and a 28-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>MOD score points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="531"/>
                <count group_id="O2" value="555"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.74" spread="4.04"/>
                    <measurement group_id="O2" value="9.07" spread="4.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.20</p_value>
            <method>ANCOVA</method>
            <method_desc>The treatment groups were compared with respect to 28-day change in MODS, adjusting for baseline MODS.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.32</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.82</ci_lower_limit>
            <ci_upper_limit>0.17</ci_upper_limit>
            <estimate_desc>The longer storage red blood cell units arm is the reference category. After adjusting for baseline MODS, the difference in the means was -0.32; positive values are in favor of longer storage duration.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Major In-hospital Post-operative Complications (Death, Stroke, Myocardial Infarction, Renal Failure, Culture-proven Sepsis/Septic Shock)</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Major In-hospital Post-operative Complications (Death, Stroke, Myocardial Infarction, Renal Failure, Culture-proven Sepsis/Septic Shock)</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>participants with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="448"/>
                <count group_id="O2" value="470"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                    <measurement group_id="O2" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.50</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.018</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.033</ci_lower_limit>
            <ci_upper_limit>0.069</ci_upper_limit>
            <estimate_desc>The difference in proportions between the two treatment arms was computed as the proportion of subjects with the event in the shorter storage duration arm minus the proportion of subjects with the event in the longer storage duration arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Major Cardiac Events (Death, Myocardial Infarction, Low Cardiac Output, Ventricular Tachycardia, Ventricular Fibrillation)</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Major Cardiac Events (Death, Myocardial Infarction, Low Cardiac Output, Ventricular Tachycardia, Ventricular Fibrillation)</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>participants with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="472"/>
                <count group_id="O2" value="496"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206"/>
                    <measurement group_id="O2" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.40</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.027</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.090</ci_lower_limit>
            <ci_upper_limit>0.035</ci_upper_limit>
            <estimate_desc>The difference in proportions between the two treatment arms was computed as the proportion of subjects with the event in the shorter storage duration arm minus the proportion of subjects with the event in the longer storage duration arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Major Pulmonary Events (Any Mechanical Ventilation From 48 Hours Post-operation to Day 7, Hospital Discharge or Death, Whichever Comes First, or Pulmonary Embolism)</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Major Pulmonary Events (Any Mechanical Ventilation From 48 Hours Post-operation to Day 7, Hospital Discharge or Death, Whichever Comes First, or Pulmonary Embolism)</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>participants with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="508"/>
                <count group_id="O2" value="537"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.018</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.059</ci_lower_limit>
            <ci_upper_limit>0.023</ci_upper_limit>
            <estimate_desc>The difference in proportions between the two treatment arms was computed as the proportion of subjects with the event in the shorter storage duration arm minus the proportion of subjects with the event in the longer storage duration arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ventilation Duration</title>
        <description>Because some subjects may experience multiple periods of ventilator use, the total duration that they were on a ventilator was compared between the two groups.</description>
        <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Ventilation Duration</title>
          <description>Because some subjects may experience multiple periods of ventilator use, the total duration that they were on a ventilator was compared between the two groups.</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="514"/>
                <count group_id="O2" value="540"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="3.9"/>
                    <measurement group_id="O2" value="2.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>Kruskal-Wallis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.62</ci_lower_limit>
            <ci_upper_limit>0.37</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Serum Creatinine From Pre-operative Value to Worst Post-operative Value</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum Creatinine From Pre-operative Value to Worst Post-operative Value</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="532"/>
                <count group_id="O2" value="558"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.58"/>
                    <measurement group_id="O2" value="0.35" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.62</p_value>
            <method>ANCOVA</method>
            <method_desc>The treatment arms were compared with respect to the change in creatinine, adjusting for the baseline creatinine value.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.08</ci_lower_limit>
            <ci_upper_limit>0.05</ci_upper_limit>
            <estimate_desc>The longer storage red blood cell units arm is the reference category. After adjusting for baseline creatinine, the difference in the means was -0.02, positive values are in favor of longer storage duration.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Troponin-I From Pre-operative Value to Worst Post-operative Value</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Troponin-I From Pre-operative Value to Worst Post-operative Value</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="443"/>
                <count group_id="O2" value="470"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.82" spread="37.64"/>
                    <measurement group_id="O2" value="14.06" spread="23.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Troponin-I values recorded as 'too low to detect' were recoded as 0 since the median value of the minimum quantitative troponin-I value obtained among all participating sites was 0.01.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.35</p_value>
            <p_value_desc>The treatment arms were compared with respect to the change in troponin-I, adjusting for the baseline troponin-I value.</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.11</ci_lower_limit>
            <ci_upper_limit>5.98</ci_upper_limit>
            <estimate_desc>The longer storage red blood cell units arm is the reference category. After adjusting for baseline troponin-I, the change in troponin-I values was 1.9 ng/mL higher in the shorter storage red blood cell units arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Lactate From Pre-operative Value to Worst Post-operative Value</title>
        <description>The arterial lactate levels were adjusted to make them comparable to venous lactate levels.</description>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lactate From Pre-operative Value to Worst Post-operative Value</title>
          <description>The arterial lactate levels were adjusted to make them comparable to venous lactate levels.</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="410"/>
                <count group_id="O2" value="437"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" spread="3.33"/>
                    <measurement group_id="O2" value="2.92" spread="5.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.10</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bilirubin From Pre-operative Value to Worst Post-operative Value</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bilirubin From Pre-operative Value to Worst Post-operative Value</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="513"/>
                <count group_id="O2" value="543"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="1.24"/>
                    <measurement group_id="O2" value="1.49" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.89</ci_lower_limit>
            <ci_upper_limit>-0.41</ci_upper_limit>
            <estimate_desc>The longer storage red blood cell units arm is the reference category. After adjusting for baseline bilirubin, the change in bilirubin values was 0.65 mg/dL lower in the shorter storage red blood cell units arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in ALT From Pre-operative Value to Worst Post-operative Value (for Pediatric Subjects Only)</title>
        <time_frame>Through post-operative day 7, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Only 4 pediatric subjects were enrolled. One treatment arm had only one subject with available data for analyzing the change in ALT. Therefore, to protect patient confidentiality, results were not entered.</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in ALT From Pre-operative Value to Worst Post-operative Value (for Pediatric Subjects Only)</title>
          <population>Only 4 pediatric subjects were enrolled. One treatment arm had only one subject with available data for analyzing the change in ALT. Therefore, to protect patient confidentiality, results were not entered.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days to First Bowel Movement</title>
        <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative bowel movement.</description>
        <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96). The mean time to an event is estimated by the area under the survival function.</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Days to First Bowel Movement</title>
          <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative bowel movement.</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96). The mean time to an event is estimated by the area under the survival function.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="538"/>
                <count group_id="O2" value="560"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.89" spread="0.17"/>
                    <measurement group_id="O2" value="6.62" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.11</p_value>
            <p_value_desc>The treatment groups were compared with respect to days to first post-operative bowel movement, adjusting for baseline MODS.</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.11</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.98</ci_lower_limit>
            <ci_upper_limit>1.25</ci_upper_limit>
            <estimate_desc>The longer storage duration arm is reference category.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days to First Solid Food</title>
        <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative solid food.</description>
        <time_frame>Through post-operative day 28, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96). The mean time to an event is estimated by the area under the survival function.</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Days to First Solid Food</title>
          <description>Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative solid food.</description>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96). The mean time to an event is estimated by the area under the survival function.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="538"/>
                <count group_id="O2" value="560"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.73" spread="0.37"/>
                    <measurement group_id="O2" value="6.18" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.22</p_value>
            <method>Regression, Cox</method>
            <method_desc>The treatment groups were compared with respect to days to first post-operative solid food, adjusting for baseline MODS.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
            <estimate_desc>The longer storage duration arm is reference category.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days Alive and Ventilator Free Through Post-op Day 28</title>
        <time_frame>Through post-op day 28</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Days Alive and Ventilator Free Through Post-op Day 28</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="511"/>
                <count group_id="O2" value="539"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.38" spread="6.40"/>
                    <measurement group_id="O2" value="25.17" spread="6.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.71</p_value>
            <method>Kruskal-Wallis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.21</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.59</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
            <estimate_desc>The longer storage duration arm is reference category.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Mechanical Ventilation More Than 48 Hours Post-operation</title>
        <time_frame>48 hours post-operation through day 28, hospital discharge, or death, whichever occurs first</time_frame>
        <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
        <group_list>
          <group group_id="O1">
            <title>Shorter-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
          <group group_id="O2">
            <title>Longer-storage Red Blood Cell Units</title>
            <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
          </group>
        </group_list>
        <measure>
          <title>Any Mechanical Ventilation More Than 48 Hours Post-operation</title>
          <population>Analysis is restricted to evaluable subjects (defined as randomized subjects who underwent cardiac surgery within 30 days after randomization and received at least one RBC transfusion between randomization and post-operative hour 96).</population>
          <units>participants with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="508"/>
                <count group_id="O2" value="537"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.015</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.057</ci_lower_limit>
            <ci_upper_limit>0.027</ci_upper_limit>
            <estimate_desc>The difference in proportions between the two treatment arms was computed as the proportion of subjects with the event in the shorter storage duration arm minus the proportion of subjects with the event in the longer storage duration arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Reported Adverse Events (AEs) include any untoward medical occurrence which occurred after a subject gave informed consent and no later than post-operative day 28, hospital discharge, or death, whichever came first.</time_frame>
      <desc>Data were collected on all serious adverse events (SAEs) and on pre-specified types of non-serious adverse events. If a subject experiences more than one occurrence of a specific adverse event, the subject was counted only once for that adverse event.</desc>
      <group_list>
        <group group_id="E1">
          <title>Shorter-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &lt;= 10 days
Red blood cell units stored &lt;= 10 days: Pre-storage leukoreduced red blood cell units stored &lt;=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
        <group group_id="E2">
          <title>Longer-storage Red Blood Cell Units</title>
          <description>Red blood cell units stored &gt;= 21 days
Red blood cell units stored &gt;= 21 days: Pre-storage leukoreduced red blood cell units stored &gt;=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="283" subjects_at_risk="538"/>
                <counts group_id="E2" subjects_affected="288" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Autoimmune thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated idioventricular rhythm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="538"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute right ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="33" subjects_affected="31" subjects_at_risk="538"/>
                <counts group_id="E2" events="28" subjects_affected="25" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="538"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Negative cardiac inotropic effect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="538"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="538"/>
                <counts group_id="E2" events="28" subjects_affected="26" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Supraventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular asystole</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Familial hypocalciuric hypercalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Heart block congenital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Antidiuretic hormone abnormality</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Visual acuity reduced transiently</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal compartment syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Internal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Application site bleeding</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="538"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Infusion related reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Infusion site dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Multi-organ disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hepatic ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="26" subjects_at_risk="538"/>
                <counts group_id="E2" events="58" subjects_affected="51" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumobilia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactoid shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute endocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Adenoviral upper respiratory infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacterial diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bronchitis pneumococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="538"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Candida pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Clostridium colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cystitis klebsiella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Enterobacter infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Enterobacter pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Genitourinary tract infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pseudomonal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Serratia infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Airway complication of anaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Allergic transfusion reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Anaphylactic transfusion reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac function disturbance postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Confusion postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Endotracheal intubation complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Iatrogenic injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Mental status changes postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Postoperative renal failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="538"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Weaning failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Wound necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated partial thromboplastin time</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level below therapeutic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aspiration pleural cavity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacteria blood identified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacteria sputum identified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood gases abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure decreased</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood urea nitrogen/creatinine ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Body temperature decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bronchoalveolar lavage abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac enzymes increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac output decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Clostridium difficile toxin test positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>ECG signs of myocardial ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Fungus culture positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>International normalised ratio abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Kidney injury molecule-1</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Methicillin-resistant staphylococcal aureus test positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>NIH stroke scale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>NIH stroke scale score increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Occult blood positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oxygen saturation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pathology test</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Radial pulse abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Red blood cells urine positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sputum culture positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Troponin I increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="538"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Feeding disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="538"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperphosphataemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperphosphatasaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypervolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="56" subjects_affected="55" subjects_at_risk="538"/>
                <counts group_id="E2" events="52" subjects_affected="46" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Metabolic alkalosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypercreatinaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atonic seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cerebral venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Essential tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Seizure anoxic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Serotonin syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Simple partial seizures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Stroke in evolution</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Adjustment disorder with depressed mood</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="538"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemoglobinuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding anovulatory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Scrotal swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute interstitial pneumonitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute lung injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="538"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Anaemic hypoxia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Apnoeic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Clotted haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="28" subjects_affected="27" subjects_at_risk="538"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="36" subjects_affected="33" subjects_at_risk="538"/>
                <counts group_id="E2" events="39" subjects_affected="39" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Idiopathic pneumonia syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Lung consolidation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Mediastinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Mediastinal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Mediastinal haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="538"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous tension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Stridor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Thoracic haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Vocal cord disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Itching scar</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pruritus allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal exploration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Allergy prophylaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aneurysm repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dialysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Extracorporeal membrane oxygenation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypotensive anaesthesia procedure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Incisional drainage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Intracerebral haematoma evacuation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pericardial drainage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Removal of foreign body</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Tracheostomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aortic intramural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Diastolic hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Diastolic hypotension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="538"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="538"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="106" subjects_affected="97" subjects_at_risk="538"/>
                <counts group_id="E2" events="96" subjects_affected="87" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Labile hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Poor peripheral circulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="324" subjects_at_risk="538"/>
                <counts group_id="E2" subjects_affected="334" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Haemolysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Accessory cardiac pathway</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="538"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="25" subjects_at_risk="538"/>
                <counts group_id="E2" events="28" subjects_affected="28" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Supraventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Familial hypocalciuric hypercalcaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Catheter site phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="89" subjects_affected="78" subjects_at_risk="538"/>
                <counts group_id="E2" events="107" subjects_affected="98" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Alloimmunisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acinetobacter infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Actinomycotic pulmonary infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Adenoviral upper respiratory infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Application site cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Aspergillosis oral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Asymptomatic bacteriuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacteriuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Catheter site cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Enterobacter tracheobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Genitourinary tract infection</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="538"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Klebsiella bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Upper respiratory fungal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Allergic transfusion reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Iatrogenic injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Postoperative renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urethral stricture traumatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Bacteria blood identified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacteria sputum identified</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bacteria urine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bilirubin conjugated abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bilirubin conjugated increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure decreased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood pressure orthostatic decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Blood urine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cardiac enzymes increased</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Differential white blood cell count normal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>ECG signs of myocardial ischaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="538"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Methicillin-resistant staphylococcal aureus test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sputum culture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Sputum culture positive</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Troponin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="538"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperphosphataemia</sub_title>
                <counts group_id="E1" events="30" subjects_affected="25" subjects_at_risk="538"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyperphosphatasaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="230" subjects_affected="187" subjects_at_risk="538"/>
                <counts group_id="E2" events="228" subjects_affected="191" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Haemoglobinuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypocalciuria</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Urine flow decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Scrotal oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemic hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Bradypnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="538"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="538"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="538"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="538"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="538"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Haemophilus influenzae type b immunisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypotensive anaesthesia procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="538"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Diastolic hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Diastolic hypotension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="538"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="538"/>
                <counts group_id="E2" events="23" subjects_affected="21" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="76" subjects_affected="71" subjects_at_risk="538"/>
                <counts group_id="E2" events="76" subjects_affected="73" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="538"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="560"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="538"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="560"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Only 4 pediatric subjects were enrolled. One treatment arm had only one subject with available data for analyzing the change in ALT outcome. Therefore, to protect patient confidentiality, results were not entered for this outcome.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Susan Assmann, PhD</name_or_title>
      <organization>New England Research Institutes</organization>
      <phone>617-972-3048</phone>
      <email>sassmann@neriscience.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

